- Report
- December 2021
- 40 Pages
Vietnam
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
United States
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
South Korea
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
Russia
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
Japan
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
Ireland
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
Germany
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
France
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
China
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 40 Pages
Brazil
From €1482EUR$1,500USD£1,235GBP
- Report
- December 2021
- 80 Pages
Africa
From €1975EUR$2,000USD£1,646GBP
- Report
- November 2024
- 50 Pages
Global
From €2617EUR$2,650USD£2,182GBP
- Report
- November 2024
- 50 Pages
Global
From €2617EUR$2,650USD£2,182GBP
- Report
- November 2024
- 50 Pages
Global
From €2617EUR$2,650USD£2,182GBP
- Report
- November 2024
- 50 Pages
Global
From €2617EUR$2,650USD£2,182GBP
- Report
- November 2024
- 50 Pages
Global
From €2617EUR$2,650USD£2,182GBP
- Report
- November 2024
- 50 Pages
Global
From €2617EUR$2,650USD£2,182GBP
- Report
- November 2024
- 50 Pages
Global
From €2617EUR$2,650USD£2,182GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,450USD£1,194GBP
- Report
- March 2022
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,450USD£1,194GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more